George Elston

George O.
Elston was the founder of Chatham Street Partners, founded in 2010, where the title held was Managing Partner.
Current jobs include Independent Trustee at DBX ETF Trust since 2010 and Chief Financial Officer & Executive Vice President at EyePoint, Inc. since 2023.
Former jobs include President & Chief Executive Officer at Enzyvant, Inc. from 2018 to 2019; President & Chief Executive Officer at Oncology Venture US, Inc. from 2017 to 2018; Director at AVANT Immunotherapeutics, Inc. in 2008; Director at Celldex Therapeutics, Inc. (Old) from 2004 to 2008; Independent Director at Celldex Therapeutics, Inc. from 2008 to 2017; Director at Celldex Research Corp.; Principal at C.
R.
Bard, Inc. (New Jersey); Chief Financial Officer, Secretary & Treasurer at Catalent JNP, Inc. from 2015 to 2016; Vice President-Finance at Elusys Therapeutics, Inc. from 2000 to 2009; Chief Financial Officer & Senior Vice President at KBI Biopharma, Inc. from 2013 to 2014; Chief Operating & Financial Officer at Optherion, Inc. from 2008 to 2010; Chief Financial Officer at Trillium USA, Inc.; Principal at Pricewaterhousecoopers LLC; and Chief Financial Officer at Enzyvant Therapeutics, Inc. from 2018 to 2019.
Education includes undergraduate studies at Pace University.